Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "6937c92e461b07808ef722e4",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "tab cyclosporine 100mg",
"description": "Cyclosporine, marketed under the brand name CYCLOPURE 100, is a potent immunosuppressant medication widely used in clinical settings to prevent organ transplant rejection and to manage various autoimmune disorders. Available as a 100mg oral capsule, CYCLOPURE 100 plays a critical role in modulating the immune system, helping patients maintain graft survival and control symptoms of immune-related diseases.\n\nProduct Description\nCYCLOPURE 100 contains cyclosporine, a cyclic polypeptide consisting of 11 amino acids, derived from the fungus Tolypocladium inflatum. It selectively inhibits the activity of T-lymphocytes, a subset of white blood cells that play a central role in immune response. By targeting these immune cells, cyclosporine helps prevent the body’s immune system from attacking transplanted organs, such as kidneys, liver, or heart, and reduces inflammation in autoimmune diseases.\n\nThe capsules are formulated for oral administration, with each capsule containing 100mg of cyclosporine. This dosage provides an effective balance between immunosuppression and safety for most adult patients, although dosing must be carefully tailored by healthcare providers based on patient response, therapeutic drug monitoring, and condition severity.\n\nUses of CYCLOPURE 100\nCYCLOPURE 100 is primarily indicated for the following medical purposes:\n\nPrevention of Organ Transplant Rejection: It is commonly prescribed to recipients of kidney, liver, heart, or other organ transplants to prevent acute and chronic rejection by suppressing immune responses that target the graft.\nAutoimmune Disease Management: Cyclosporine is effective in treating autoimmune disorders such as rheumatoid arthritis, psoriasis, and certain types of nephrotic syndrome. By reducing immune system overactivity, it helps alleviate symptoms such as joint inflammation, skin lesions, and kidney damage.\n\nSevere Atopic Dermatitis: In cases where conventional treatments are ineffective, cyclosporine may be used to control symptoms of severe eczema by modulating immune hyperreactivity.\n\nOther Off-Label Uses: Occasionally, cyclosporine is used for other immune-mediated conditions like uveitis, Crohn’s disease, and some forms of lupus nephritis depending on physician discretion.\n\nKey Benefits\nEffective Immunosuppression: CYCLOPURE 100 is known for its potent ability to suppress immune responses selectively, significantly reducing the risk of organ rejection after transplantation and improving graft survival rates.\n\nVersatility in Autoimmune Conditions: Beyond organ transplantation, cyclosporine’s immunomodulatory effects provide relief in autoimmune diseases by controlling inflammation and immune overactivity that cause tissue damage.\n\nImprovement in Quality of Life: By controlling disease symptoms such as joint pain, skin inflammation, or kidney impairment, CYCLOPURE 100 enables patients to experience improved physical comfort and daily functioning.\n\nOral Administration Convenience: The capsule form ensures ease of use and better patient compliance compared to injectable immunosuppressants, allowing therapy to be managed on an outpatient basis.\n\nTherapeutic Drug Monitoring: The availability of blood level monitoring helps customize dosage and maximize therapeutic effects while minimizing toxicity.\n\nSide Effects and Precautions\nWhile CYCLOPURE 100 is highly beneficial, it carries a risk of side effects due to its immunosuppressive nature and systemic effects. Common, less severe side effects include:\n\nGingival hyperplasia (gum overgrowth)\n\nTremors or mild neurological symptoms\n\nHypertension (high blood pressure)\n\nIncreased hair growth (hypertrichosis)\n\nGastrointestinal disturbances (nausea, diarrhea)\n\nMore serious adverse effects, which require immediate medical attention, can include:\n\nNephrotoxicity: Cyclosporine can affect kidney function; regular monitoring of kidney function tests is essential.\n\nIncreased Risk of Infections: Suppression of the immune system increases vulnerability to bacterial, viral, and fungal infections.\n\nHepatotoxicity: Liver function should be monitored, as cyclosporine may cause elevated liver enzymes or more severe liver damage.\n\nMalignancies: Long-term use has been associated with an increased risk of certain cancers, particularly lymphomas and skin cancers.\n\nElectrolyte Imbalances: Hypomagnesemia and hyperkalemia are possible and require monitoring.\n\nPatients must inform their healthcare providers about other medications they take, as cyclosporine has significant drug interactions that can affect its blood levels and toxicity risk, including with antibiotics, antifungals, anticonvulsants, and others.\n\nConclusion\nCYCLOPURE 100 (Cyclosporine 100mg) stands as a cornerstone immunosuppressant medication that plays a vital role in preventing organ rejection and managing autoimmune diseases. Its targeted immunosuppressive action effectively reduces disease burden, enhances graft survival, and improves patients’ quality of life. Although it entails risks of side effects, careful medical supervision, therapeutic drug monitoring, and adherence to prescribed dosing protocols effectively mitigate these concerns.\n\nFor patients undergoing organ transplantation or those with autoimmune conditions unresponsive to standard therapies, CYCLOPURE 100 provides a valuable therapeutic solution. Always consult a healthcare professional before starting or adjusting therapy with CYCLOPURE 100 to ensure the safest and most effective use tailored to individual clinical needs.",
"price": 1014.0,
"discountamount": 305.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2239,
"imageuri": "https://productimages.withfloats.com/actual/6937c930ed26b2c06ce34f7e.jpeg",
"tileimageuri": "https://productimages.withfloats.com/tile/6937c930ed26b2c06ce34f7e.jpeg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-12-09T07:01:02.399Z",
"updatedon": "2026-03-30T07:51:22.499Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/tab-cyclosporine-100mg/2239",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CYCLOPURE 100",
"category": "NEUROLOGY RANGE",
"tags": [
"Cyclosporine",
"fungus",
"white blood cells.",
"Prevention of Organ Transplant Rejection.",
"Autoimmune Disease Management.",
"tab cyclosporine 100mg.",
"cap cyclosporine 100mg.",
"cyclosporine 100mg price.",
"cyclosporine 100mg tablet.",
"cap cyclosporine 100mg uses in hindi.",
"cost of cyclosporine 100mg.",
"cyclosporine 100mg tablet price."
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "66d6df52731125bdd4e1003b",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VALGANCICLOVIR TABLET 450 MG",
"description": "VOLANE SOURCE 450 is a pharmaceutical tablet containing Valganciclovir at a dosage strength of 450 mg. It is a potent antiviral medication primarily designed to treat and prevent certain viral infections caused by cytomegalovirus (CMV), especially in immunocompromised patients such as those undergoing organ transplants or living with HIV/AIDS. Manufactured adhering to strict quality standards under the tablet IP (Indian Pharmacopoeia), VOLANE SOURCE 450 ensures consistent efficacy and safety for patients requiring antiviral therapy.\n\nComposition and Pharmacological Profile\nEach film-coated tablet of VOLANE SOURCE 450 contains 450 mg of Valganciclovir as the active ingredient. Valganciclovir is a prodrug of ganciclovir, meaning it is converted in the body into ganciclovir, which is the active antiviral agent. Its mechanism involves inhibiting viral DNA synthesis by competing with deoxyguanosine triphosphate for incorporation into viral DNA, thereby suppressing the replication of CMV and related herpes viruses.\n\nPrimary Uses of VOLANE SOURCE 450\nTreatment of CMV Retinitis: CMV retinitis is a serious viral eye infection common in patients with weakened immune systems, such as AIDS patients. It leads to inflammation and possible vision loss if left untreated. VOLANE SOURCE 450 is a frontline therapy used to halt the progression of this infection.\n\nPrevention of CMV Disease in Transplant Patients: Solid organ transplant recipients and bone marrow transplant patients are at high risk of CMV infection due to immunosuppressive drugs. Prophylactic use of VOLANE SOURCE 450 helps in preventing CMV disease in these vulnerable groups.\n\nTreatment of CMV Infection: Apart from retinitis, CMV can cause systemic infections affecting multiple organs, including lungs, digestive tract, and nervous system. VOLANE SOURCE 450 is used for managing such infections effectively.\n\nPart of Combination Therapy: It may also be prescribed alongside other antiviral agents as part of combination treatment protocols tailored to complex viral infections, enhancing viral suppression.\n\nKey Benefits of Using VOLANE SOURCE 450\nHigh Oral Bioavailability: Being a prodrug, Valganciclovir is well absorbed orally and converted efficiently to ganciclovir in the body, enabling effective antiviral levels.\n\nWide Spectrum of Action: Targets multiple herpesviruses with high specificity, primarily cytomegalovirus, reducing viral load and infection severity.\n\nReduced Risk of CMV Disease Post-Transplant: By preventing CMV infection in transplant recipients, VOLANE SOURCE 450 significantly lowers the risk of post-transplant complications related to viral disease.\n\nConvenient Oral Dosage: Unlike intravenous ganciclovir, VOLANE SOURCE 450 allows for easier home administration, improving patient compliance and quality of life.\n\nEffective Against Resistant Strains: Used in recurrent and resistant CMV infections, especially where other therapies fail.\n\nProtects Vision: In CMV retinitis patients, prompt use of VOLANE SOURCE 450 can preserve vision and prevent blindness due to viral damage.\n\nRecommended Dosage and Administration\nThe dosing of VOLANE SOURCE 450 depends on the condition being treated, kidney function, and patient immune status. It is typically prescribed by healthcare professionals following careful medical assessment.\n\nFor CMV retinitis treatment, the initial dose is usually higher and then tapered down for maintenance.\n\nFor CMV prophylaxis post-transplant, a standard dose is taken once or twice daily for several months.\n\nIt is advised to swallow tablets whole with food to enhance absorption.\n\nRegular monitoring of blood counts and kidney function is essential during therapy since the drug can impact bone marrow and renal function.\n\nPotential Side Effects of VOLANE SOURCE 450\nLike any potent antiviral medication, VOLANE SOURCE 450 can cause side effects. Awareness and timely reporting to a healthcare provider are important to manage these effects safely.\n\nCommon side effects include:\n\nGastrointestinal symptoms: Nausea, vomiting, diarrhea, and abdominal pain.\n\nBone marrow suppression: Leading to anemia, neutropenia (low neutrophils), or thrombocytopenia (low platelets), which increase infection risks and bruising.\n\nHeadache and fatigue: Mild to moderate headache and tiredness may occur.\n\nFever and infections: Due to immune suppression, secondary infections may arise.\n\nElectrolyte imbalance: Occasionally, abnormalities in blood calcium or potassium levels.\n\nRare hypersensitivity reactions: Skin rash, itching, or swelling which require immediate medical attention.\n\nPrecautions and Contraindications\nPatients with severe renal impairment require dose adjustments or alternative therapies to avoid toxicity.\n\nPregnant or breastfeeding women should avoid this drug due to potential harm to the fetus or infant.\n\nRegular blood tests are necessary to monitor for hematologic or renal side effects.\n\nUse caution in patients with pre-existing neutropenia or anemia.\n\nConclusion\nVOLANE SOURCE 450 (Valganciclovir Tablet IP 450 mg) represents a reliable and efficacious antiviral therapy specifically targeting cytomegalovirus infections. Its role in treatment and prevention of CMV-related diseases, especially among immunocompromised patients, makes it invaluable in clinical practice.\n\nIts oral formulation allows for easy administration and effective drug delivery, improving patient adherence and outcomes. While the risk of side effects exists, careful monitoring and adherence to prescribed dosages minimize complications.\n\nOverall, VOLANE SOURCE 450 offers a potent solution against serious viral infections, helping preserve health, prevent complications, and improve quality of life for vulnerable patient populations.\n\n",
"price": 3944.0,
"discountamount": 2367.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"viral DNA",
"rare cases",
"Key Benefits",
"CMV Retinitis",
"VOLANE SOURCE",
"CMV infection",
"various organs",
"kidney function",
"prescribed course",
"chain termination",
"active ingredient",
"organ transplants",
"medical condition",
"blood cell counts",
"healthcare provider",
"severe side effects",
"Common Side Effects",
"Regular blood tests",
"complete eradication",
"antiviral medication",
"high bioavailability",
"severe eye infection",
"Serious Side Effects",
"high-risk individuals",
"convenient oral option",
"bone marrow suppression",
"weakened immune systems",
"VALGANCICLOVIR TABLET IP",
"High Oral Bioavailability",
"Immediate medical attention"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1950,
"imageuri": "https://productimages.withfloats.com/actual/6936b55236477d52c1e94700.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6936b55236477d52c1e94700.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-09-03T10:05:06.943Z",
"updatedon": "2026-03-12T06:40:40.942Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//valganciclovir-tablet-450-mg/1950",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VOLANE SOURCE 450",
"category": "CARDIOLOGYRANGE",
"tags": [
"VALGANCICLOVIR TABLET IP 450 MG USUE",
"Valganciclovir Tablet IP 450 mg",
"infections caused by cytomegalovirus (CMV).",
"VOLANE SOURCE 450",
"helps control the spread of the CMV infection within the body",
"high bioavailability",
"improve quality of life for vulnerable patient populations",
"valganciclovir tablet 450 mg uses",
"valganciclovir 450 mg tablet price in India",
"valganciclovir 450 mg dosage information",
"valganciclovir tablet 450 mg composition",
"valganciclovir 450 mg tablet side effects",
"valganciclovir 450 mg tablet benefits",
"what is valganciclovir tablet 450 mg used for",
"how valganciclovir 450 mg works",
"valganciclovir 450 mg tablet mechanism of action",
"valganciclovir tablet 450 mg storage instructions",
"valganciclovir 450 mg tablet administration guide",
"buy valganciclovir 450 mg tablet online",
"valganciclovir 450 mg tablet supplier India",
"valganciclovir tablet 450 mg wholesale price",
"valganciclovir 450 mg tablet manufacturer",
"valganciclovir 450 mg tablet distributor",
"valganciclovir 450 mg generic tablet",
"valganciclovir 450 mg tablet substitute",
"valganciclovir 450 mg antiviral tablet",
"when to take valganciclovir 450 mg tablet"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6662b0528ecffe165c354a72",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "N Acetylecystine 150mg + Taurine 500mg",
"description": "STYLETAURINE\nN Acetylecystine 150mg + Taurine 500mg\nTacrenolime 0.50 is a medication that comes in the form of Tacrolimus Capsules, with each capsule containing 0.5mg of Tacrolimus. Tacrolimus is an immunosuppressant drug that is commonly used to prevent rejection after organ transplantation. It works by suppressing the immune system's response to foreign substances, thereby reducing the risk of the body rejecting a transplanted organ.\n\nTacrolimus capsules are typically prescribed as part of a comprehensive transplant treatment regimen. The dosage and frequency of administration are determined by your healthcare provider based on factors such as your medical condition, response to treatment, and other medications you may be taking.\n\nIt's important to follow your doctor's instructions carefully when taking Tacrenolime 0.50. Do not adjust the dosage or stop taking the medication without consulting your healthcare provider. Missing doses or discontinuing treatment abruptly can increase the risk of transplant rejection or other complications.\n\nCommon side effects of Tacrenolime 0.50 may include nausea, vomiting, diarrhea, headache, dizziness, and changes in kidney function. Inform your doctor if you experience any persistent or severe side effects while taking this medication.\n\nTacrenolime 0.50 is an essential part of post-transplant care, helping to ensure the success of the transplant and improve long-term outcomes. Always keep your healthcare provider informed about any changes in your health or medications while using Tacrenolime 0.50. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \nhttps://www.sterisonline.com/product/styletaurine-133682\n\n\n\n\n\n\n",
"price": 195.0,
"discountamount": 59.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"form",
"Call",
"risk",
"body",
"0.5mg",
"Email",
"Order",
"dosage",
"doctor",
"nausea",
"success",
"changes",
"factors",
"vomiting",
"diarrhea",
"headache",
"WhatsApp",
"response",
"frequency",
"dizziness",
"persistent",
"Tacrenolime",
"sterispharma",
"instructions",
"sterisonline",
"STYLETAURINE",
"immune system",
"Missing doses",
"essential part",
"administration",
"kidney function",
"N Acetylecystine",
"other medications",
"medical condition",
"long-term outcomes",
"foreign substances",
"Tacrolimus Capsules",
"Common side effects",
"severe side effects",
"healthcare provider",
"other complications",
"post-transplant care",
"transplant rejection",
"organ transplantation",
"immunosuppressant drug",
"comprehensive transplant treatment regimen"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1497,
"imageuri": "https://productimages.withfloats.com/actual/6662b05d637f8700d7cb02a4.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6662b05d637f8700d7cb02a4.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T07:01:38.891Z",
"updatedon": "2026-03-13T05:44:57.644Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//n-acetylecystine-150mg-taurine-500mg/1497",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "STYLETAURINE",
"category": "NEPHROLOGYRANGE",
"tags": [
"STYLETAURINE",
"N Acetylecystine 150mg",
"Taurine 500mg",
"n-acetylcysteine & taurine tablets brands",
"N Acetylcysteine and Taurine tablets dose",
"Tazytyl Uses"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6634cc9d4194481fc81fe331",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Cyclosporine 100mg",
"description": "CYCLOPURE 100 \nCyclosporine 100 mg\nCYCLOPURE 100™ is a high-strength oral immunosuppressive formulation containing cyclosporine 100 mg, developed to provide reliable and consistent immune system modulation for patients requiring intensive therapy. As a calcineurin inhibitor, cyclosporine plays a vital role in transplant medicine and in the treatment of severe autoimmune and inflammatory disorders.\n\nCYCLOPURE 100™ is designed for patients who require higher dosing as part of their therapeutic regimen. The 100 mg capsule strength supports simplified dosing schedules and improved treatment adherence, particularly in organ transplant recipients and individuals with moderate to severe immune-mediated conditions.\n\nManufactured under strict pharmaceutical quality standards, CYCLOPURE 100™ ensures dose precision, stability, and safety when used under medical supervision.\n\nMechanism of Action\n\nCyclosporine works by selectively inhibiting calcineurin, an intracellular enzyme necessary for activating T-lymphocytes. T-cells are critical mediators of immune responses, particularly in organ rejection and autoimmune inflammation.\n\nBy blocking calcineurin:\n\nT-cell activation is reduced\n\nProduction of pro-inflammatory cytokines decreases\n\nImmune-mediated tissue damage is minimized\n\nRisk of transplant rejection is lowered\n\nThis targeted suppression allows CYCLOPURE 100™ to control immune overactivity while preserving other immune functions, making it highly effective for long-term immune regulation.\n\nIndications and Therapeutic Uses\n\nCYCLOPURE 100™ is prescribed for a variety of medical conditions where immune suppression is necessary.\n\n1. Organ Transplantation\n\nCYCLOPURE 100™ is widely used in:\n\nKidney transplantation\n\nLiver transplantation\n\nHeart transplantation\n\nIts primary role is to prevent the immune system from attacking the transplanted organ, thereby improving graft survival and long-term transplant success.\n\n2. Autoimmune Disorders\n\nCyclosporine is also effective in treating immune-related conditions such as:\n\nRheumatoid arthritis\n\nSevere psoriasis\n\nAtopic dermatitis\n\nNephrotic syndrome\n\nIn these disorders, the immune system mistakenly attacks healthy tissues. CYCLOPURE 100™ helps reduce inflammation, pain, and tissue damage.\n\n3. Other Severe Inflammatory Conditions\n\nUnder specialist supervision, CYCLOPURE 100™ may be used for additional immune-mediated conditions that do not respond adequately to conventional therapies.\n\nKey Benefits of CYCLOPURE 100™\n1. Strong Immunosuppressive Action\n\nThe 100 mg strength provides effective immune suppression for patients requiring higher therapeutic doses, especially in transplant settings.\n\n2. Improved Organ Survival\n\nIn transplant recipients, CYCLOPURE 100™ significantly reduces the risk of acute and chronic organ rejection, enhancing long-term graft function.\n\n3. Symptom Relief in Autoimmune Diseases\n\nPatients may experience:\n\nReduced joint inflammation and stiffness\n\nDecreased skin lesions and redness\n\nImproved kidney function in nephrotic syndrome\n\nReduced flare-ups of inflammatory conditions\n\n4. Flexible Dosing Options\n\nThe 100 mg capsule allows physicians to create individualized treatment plans, often in combination with lower strengths such as 25 mg capsules to achieve precise dosing.\n\n5. Established Clinical Use\n\nCyclosporine has decades of clinical experience worldwide, making it a well-understood and trusted medication in immune therapy.\n\n6. Enhanced Quality of Life\n\nBy stabilizing immune activity, CYCLOPURE 100™ helps patients regain functional independence, reduce hospitalizations, and maintain overall health stability.\n\nDosage and Administration\n\nCYCLOPURE 100™ should be taken strictly according to a physician’s prescription. Dosage varies based on:\n\nBody weight\n\nType of transplant or condition\n\nBlood cyclosporine levels\n\nKidney and liver function\n\nConcurrent medications\n\nAdministration Guidelines\n\nTake capsules at the same time each day.\n\nSwallow whole with water.\n\nDo not crush or chew the capsule.\n\nMaintain consistency with food intake (always with food or always without).\n\nRegular blood tests are essential to monitor cyclosporine levels and adjust dosage as needed. Therapeutic drug monitoring ensures optimal efficacy while minimizing toxicity.\n\nPossible Side Effects\n\nBecause CYCLOPURE 100™ suppresses immune function, side effects may occur, particularly at higher doses.\n\nCommon Side Effects\n\nHigh blood pressure (hypertension)\n\nHeadache\n\nTremors\n\nGum overgrowth\n\nIncreased hair growth\n\nNausea or abdominal discomfort\n\nThese effects are often dose-related and may improve with dosage adjustments.\n\nKidney-Related Effects\n\nCyclosporine can affect kidney function, particularly at higher doses. Monitoring kidney parameters is essential.\n\nWarning signs include:\n\nSwelling in extremities\n\nDecreased urine output\n\nElevated creatinine levels\n\nIncreased Infection Risk\n\nSince the immune system is suppressed, patients may be more susceptible to infections.\n\nSymptoms to monitor:\n\nFever\n\nPersistent cough\n\nSore throat\n\nUnusual fatigue\n\nLiver Function Changes\n\nElevated liver enzymes may occur and require monitoring.\n\nElectrolyte Imbalance\n\nCyclosporine may increase potassium levels and alter magnesium levels.\n\nLong-Term Risks\n\nWith prolonged use, there is a potential increased risk of:\n\nCertain malignancies (particularly skin cancers)\n\nLymphoproliferative disorders\n\nThese risks are carefully managed through medical supervision and routine screening.\n\nPrecautions and Warnings\n\nBefore starting CYCLOPURE 100™, patients should inform their healthcare provider if they have:\n\nPre-existing kidney or liver disease\n\nUncontrolled hypertension\n\nHistory of malignancy\n\nActive infections\n\nPregnancy or breastfeeding plans\n\nDrug Interactions\n\nCyclosporine interacts with numerous medications, including:\n\nCertain antibiotics and antifungals\n\nCalcium channel blockers\n\nAntiepileptic drugs\n\nOther immunosuppressants\n\nHerbal supplements such as St. John’s Wort\n\nPatients must disclose all medications and supplements to their healthcare provider.\n\nVaccination Advisory\n\nLive vaccines are generally contraindicated during cyclosporine therapy due to reduced immune response.\n\nLifestyle Recommendations\n\nTo support safe treatment with CYCLOPURE 100™:\n\nMonitor blood pressure regularly\n\nAttend scheduled laboratory testing appointments\n\nMaintain excellent oral hygiene\n\nLimit sun exposure and use sunscreen\n\nPractice infection prevention measures\n\nFollow dietary guidance, especially regarding potassium intake\n\nClose collaboration with healthcare providers ensures safe and effective long-term therapy.\n\nStorage Instructions\n\nStore at room temperature\n\nKeep away from moisture and heat\n\nProtect from direct sunlight\n\nKeep out of reach of children\n\nDo not use expired medication.\n\nWho Should Use CYCLOPURE 100™?\n\nCYCLOPURE 100™ is suitable for:\n\nOrgan transplant recipients requiring stable immune suppression\n\nPatients with moderate to severe autoimmune conditions\n\nIndividuals who require higher-dose cyclosporine therapy under specialist supervision\n\nIt should always be prescribed and monitored by a qualified healthcare professional.\n\nConclusion\n\nCYCLOPURE 100™ (Cyclosporine 100 mg) is a potent and clinically established immunosuppressive therapy designed to prevent organ rejection and manage serious autoimmune disorders. Its targeted inhibition of T-cell activation provides effective immune modulation, making it a cornerstone medication in transplant medicine and advanced inflammatory disease management.\n\n",
"price": 1274.0,
"discountamount": 383.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"heat",
"body",
"risk",
"100mg",
"signs",
"cases",
"nausea",
"Storage",
"diarrhea",
"vomiting",
"headache",
"moisture",
"psoriasis",
"treatment",
"infections",
"Drug Class",
"components",
"prevention",
"medication",
"Indications",
"Precautions",
"supervision",
"malignancies",
"Cyclosporine",
"prescription",
"immune system",
"Administration",
"liver toxicity",
"kidney function",
"organ rejection",
"transplant type",
"kidney problems",
"hypersensitivity",
"room temperature",
"autoimmune diseases",
"individual response",
"Common side effects",
"healthcare provider",
"high blood pressure",
"rheumatoid arthritis",
"Serious side effects",
"transplant recipients",
"immunosuppressant drug",
"Cyclopure 100 capsules",
"uncontrolled hypertension",
"heart transplant patients",
"Oral Capsules Composition",
"Immunosuppressant Dosage Form",
"qualified healthcare professional"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1061,
"imageuri": "https://productimages.withfloats.com/actual/6634cca7085b40e38314d711.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6634cca7085b40e38314d711.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-05-03T11:38:05.78Z",
"updatedon": "2026-03-12T09:26:41.912Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//cyclosporine-100mg/1061",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CYCLOPURE 100",
"category": "ORTHOLOGYRANG",
"tags": [
"cyclosporine 100 mg capsule dosage for kidney transplant patients",
"cyclosporine 100 mg soft gelatin capsule brand comparison",
"cyclosporine 100 mg trough level monitoring range",
"cyclosporine 100 mg dose adjustment in renal impairment",
"what is cyclosporine 100 mg used for",
"how to take cyclosporine 100 mg capsules safely",
"when to monitor blood levels on cyclosporine 100 mg",
"buy cyclosporine 100 mg capsules online",
"generic cyclosporine 100 mg cost per capsule"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6634cb0595821c1e2ceadc54",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Cyclosporine 25 mg",
"description": "CYCLOPURE 25 \nCyclosporin 25 mg\nCYCLOPURE 25™ is a high-quality oral formulation containing Cyclosporine 25 mg, a potent immunosuppressive medication widely used in transplant medicine and the management of certain autoimmune and inflammatory disorders. Designed for precise dosing and reliable absorption, CYCLOPURE 25™ plays a critical role in preventing organ rejection and controlling overactive immune responses.\n\nCyclosporine belongs to a class of medicines known as calcineurin inhibitors. It works by selectively suppressing specific immune cells that contribute to inflammation and immune-mediated damage. By carefully modulating immune function, CYCLOPURE 25™ helps protect transplanted organs and reduces symptoms associated with autoimmune conditions.\n\nEach capsule of CYCLOPURE 25™ is manufactured under stringent pharmaceutical quality standards to ensure safety, consistency, and therapeutic reliability.\n\nHow CYCLOPURE 25™ Works\n\nCyclosporine exerts its effect by inhibiting calcineurin, an enzyme involved in activating T-lymphocytes (a type of white blood cell). T-cells play a central role in the immune response, especially in organ rejection and autoimmune diseases.\n\nWhen calcineurin is blocked:\n\nActivation of T-cells is reduced\n\nProduction of inflammatory cytokines decreases\n\nImmune system activity becomes controlled\n\nRisk of organ rejection is minimized\n\nAutoimmune inflammation is suppressed\n\nThis targeted mechanism allows CYCLOPURE 25™ to effectively reduce harmful immune responses while maintaining necessary immune function.\n\nIndications and Uses\n\nCYCLOPURE 25™ is commonly prescribed for:\n\n1. Organ Transplantation\n\nKidney transplant\n\nLiver transplant\n\nHeart transplant\n\nIt helps prevent the body from rejecting a transplanted organ by suppressing immune reactions against the new tissue.\n\n2. Autoimmune Disorders\n\nRheumatoid arthritis\n\nPsoriasis\n\nSevere atopic dermatitis\n\nCertain forms of nephrotic syndrome\n\nIn these conditions, the immune system mistakenly attacks healthy tissues. CYCLOPURE 25™ helps reduce inflammation and tissue damage.\n\n3. Other Immune-Mediated Conditions\n\nIt may also be prescribed for selected inflammatory or immune-related disorders as determined by a healthcare professional.\n\nKey Benefits of CYCLOPURE 25™\n1. Effective Prevention of Organ Rejection\n\nCYCLOPURE 25™ is a cornerstone medication in transplant medicine, significantly improving long-term graft survival rates.\n\n2. Targeted Immune Suppression\n\nUnlike broad-spectrum immunosuppressants, cyclosporine specifically targets T-cell activation, offering focused immune modulation.\n\n3. Reduction in Autoimmune Symptoms\n\nPatients with rheumatoid arthritis, psoriasis, or severe dermatitis may experience:\n\nReduced joint pain and swelling\n\nDecreased skin lesions and inflammation\n\nImproved mobility and comfort\n\n4. Proven Clinical Track Record\n\nCyclosporine has been used for decades worldwide and remains a trusted therapy in transplant and autoimmune care.\n\n5. Precise 25 mg Dosing\n\nThe 25 mg capsule strength allows physicians to tailor treatment regimens based on individual patient needs and therapeutic drug monitoring.\n\n6. Improved Quality of Life\n\nBy controlling immune overactivity, CYCLOPURE 25™ helps patients maintain better organ function and symptom control, leading to improved daily functioning.\n\nDosage and Administration\n\nCYCLOPURE 25™ should always be taken exactly as prescribed by a healthcare provider. Dosage varies depending on:\n\nThe medical condition being treated\n\nBody weight\n\nBlood cyclosporine levels\n\nKidney function\n\nOther concurrent medications\n\nGeneral guidelines:\n\nTake capsules at the same time each day.\n\nSwallow whole with water.\n\nDo not crush or chew.\n\nMaintain consistency with regard to meals (either always with food or always without).\n\nTherapeutic drug monitoring is often required to measure blood cyclosporine levels and adjust dosage accordingly. Regular laboratory tests are essential during treatment.\n\nPossible Side Effects\n\nBecause CYCLOPURE 25™ affects the immune system, side effects may occur. Some are mild, while others require medical supervision.\n\nCommon Side Effects\n\nIncreased blood pressure\n\nHeadache\n\nTremors (especially in hands)\n\nIncreased hair growth (hypertrichosis)\n\nGum overgrowth\n\nNausea or stomach discomfort\n\nThese side effects may vary in intensity and often depend on dosage.\n\nKidney-Related Effects\n\nCyclosporine can affect kidney function. Monitoring kidney parameters is essential during therapy. Signs of kidney-related issues include:\n\nDecreased urine output\n\nSwelling in legs or ankles\n\nElevated creatinine levels\n\nIncreased Risk of Infections\n\nSince CYCLOPURE 25™ suppresses immune function, patients may become more susceptible to infections.\n\nSymptoms to watch for:\n\nFever\n\nPersistent sore throat\n\nUnusual fatigue\n\nSigns of localized infection\n\nOther Potential Serious Effects\n\nLiver dysfunction\n\nElevated potassium levels\n\nIncreased risk of certain malignancies (especially with long-term use)\n\nNeurological symptoms in rare cases\n\nPatients should immediately report unusual symptoms to their healthcare provider.\n\nPrecautions and Warnings\n\nBefore starting CYCLOPURE 25™, inform your healthcare provider if you:\n\nHave kidney disease\n\nHave liver disease\n\nHave uncontrolled high blood pressure\n\nHave a history of cancer\n\nAre pregnant or breastfeeding\n\nAre taking other immunosuppressants\n\nDrug Interactions\n\nCyclosporine interacts with many medications, including:\n\nCertain antibiotics\n\nAntifungal medications\n\nCalcium channel blockers\n\nAnti-seizure medications\n\nHerbal supplements such as St. John’s Wort\n\nAlways inform your physician about all medications and supplements you are taking.\n\nVaccination Precaution\n\nLive vaccines should generally be avoided while taking CYCLOPURE 25™, as immune suppression may increase risk of infection.\n\nLifestyle Considerations\n\nTo optimize therapy with CYCLOPURE 25™:\n\nMonitor blood pressure regularly\n\nFollow recommended laboratory testing schedules\n\nMaintain proper oral hygiene to prevent gum overgrowth\n\nAvoid excessive sun exposure due to increased skin cancer risk\n\nPractice infection prevention measures\n\nA balanced diet and consistent medical follow-up significantly enhance treatment safety and effectiveness.\n\nStorage Instructions\n\nStore at room temperature\n\nProtect from moisture and direct sunlight\n\nKeep out of reach of children\n\nDo not use beyond the expiration date\n\nWho Should Use CYCLOPURE 25 ™?\n\nCYCLOPURE 25™ is suitable for:\n\nOrgan transplant recipients\n\nPatients with severe autoimmune disorders unresponsive to first-line therapies\n\nIndividuals requiring controlled immune suppression under specialist supervision\nIt should only be used under close medical guidance and regular monitoring.\nConclusion\nCYCLOPURE 25™ (Cyclosporine 25 mg) is a powerful and clinically established immunosuppressive medication designed to protect transplanted organs and manage serious autoimmune conditions. By specifically targeting T-cell activation, it offers precise immune modulation while preserving essential immune functions.\n\n",
"price": 342.0,
"discountamount": 103.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"body",
"risk",
"food",
"cases",
"class",
"drugs",
"Usage",
"heart",
"nausea",
"doctor",
"weight",
"kidneys",
"vomiting",
"diarrhea",
"headache",
"symptoms",
"Benefits",
"concerns",
"treatment",
"psoriasis",
"infections",
"medication",
"supplements",
"Precautions",
"drug levels",
"Composition",
"Interactions",
"liver damage",
"inflammation",
"Cyclosporine",
"instructions",
"manufacturer",
"kidney function",
"organ rejection",
"herbal products",
"immune response",
"kidney problems",
"25mg dosage form",
"active ingredient",
"recommended dosage",
"Regular monitoring",
"high blood pressure",
"transplanted organs",
"CYCLOPURE 25 tablet",
"autoimmune diseases",
"regular blood tests",
"transplant patients",
"Common side effects",
"rheumatoid arthritis",
"Serious side effects",
"calcineurin inhibitors",
"healthcare professional",
"various medical conditions",
"inflammatory bowel disease",
"potent immunosuppressive agent"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1059,
"imageuri": "https://productimages.withfloats.com/actual/6634cb0f022485c14950902a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6634cb0f022485c14950902a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-05-03T11:31:17.295Z",
"updatedon": "2026-03-12T09:24:57.505Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//cyclosporine-25-mg/1059",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CYCLOPURE 25",
"category": "ORTHOLOGYRANG",
"tags": [
"cyclosporine 25 mg capsule dosage for kidney transplant",
"cyclosporine 25 mg twice daily dosing schedule",
"cyclosporine 25 mg oral capsule storage instructions",
"cyclosporine 25 mg generic vs brand difference",
"what is cyclosporine 25 mg used for",
"can cyclosporine 25 mg cause high blood pressure",
"is cyclosporine 25 mg safe long term",
"buy cyclosporine 25 mg capsules online",
"cyclosporine 25 mg price per capsule",
"cyclosporine 25 mg capsule manufacturer"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6ae5ddc42400c0ad258fb750",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Mycophenolic Acid Delayed-Release Tablets USP 360 mg",
"description": "MYCOFORTIC S 360 is a pharmaceutical formulation containing Mycophenolic Acid Delayed-Release Tablets USP 360 mg. Mycophenolic Acid belongs to a class of medicines known as immunosuppressants. It is used to help prevent organ rejection in patients who have undergone kidney transplantation, as part of a combination immunosuppressive treatment regimen prescribed by a qualified healthcare professional.\n\nOrgan transplantation is an important medical procedure that helps patients with end-stage organ disease improve their quality of life. However, the body's immune system may recognize a transplanted organ as foreign and attempt to attack it. This immune response can lead to organ rejection.\n\nMYCOFORTIC S 360 contains Mycophenolic Acid, an active pharmaceutical ingredient that helps suppress certain immune responses. It works by inhibiting the proliferation of lymphocytes, which are important cells involved in the body's immune response.\n\nWith its delayed-release tablet formulation, MYCOFORTIC S 360 is designed to deliver Mycophenolic Acid through a specialized release mechanism. It is intended for use under strict medical supervision as part of an individualized post-transplant treatment plan.",
"price": 816.0,
"discountamount": 245.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2510,
"imageuri": "https://productimages.withfloats.com/actual/6ae5ddc7bc27d43423ad0aec.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ae5ddc7bc27d43423ad0aec.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-31T12:23:32.198Z",
"updatedon": "2026-10-31T12:23:32.198Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//mycophenolic-acid-delayed-release-tablets-usp-360-mg/2510",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "MYCOFORTIC S 360",
"category": null,
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad74702e53c888beeab308d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets",
"description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n",
"price": 210.0,
"discountamount": 147.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2505,
"imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:48:34.116Z",
"updatedon": "2026-10-20T10:48:34.116Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 10",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad7442bf24c5a4bbccf4b10",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets",
"description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.",
"price": 230.0,
"discountamount": 69.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2504,
"imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:36:27.325Z",
"updatedon": "2026-10-20T10:36:27.325Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 25",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a952bdada41ea9aeeec5e4a",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Semaglutide injection 8 mg",
"description": "The semaglutide injection, 8 mg, contains a total of 8 mg of semaglutide, a long-acting GLP-1 receptor agonist. It is used under medical supervision as part of treatment for appropriate adults with type 2 diabetes mellitus and, depending on the specific approved product and indication, for cardiovascular risk reduction and chronic weight management.\n1. Product Overview & Specifications\nAn 8 mg/3 mL semaglutide pen contains 8 mg of the active medicine in a 3 mL delivery system. When specifically designed to provide 2 mg per weekly dose, the total quantity can provide four 2 mg doses.\nActive Ingredient: Semaglutide\nTotal Strength: 8 mg\nExample Presentation: 8 mg/3 mL multi-dose pen\nDrug Class: GLP-1 receptor agonist\nRoute: Subcutaneous injection\nCommon Injection Areas: Abdomen, thigh, or upper arm\nAdministration: Once weekly, according to the prescribed schedule\nMechanism of Action\nSemaglutide mimics the activity of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). It acts on GLP-1 receptors involved in blood-glucose regulation, digestion, and appetite.\nImproves glucose-dependent insulin release: Semaglutide encourages the pancreas to release insulin when blood glucose levels are elevated.\nReduces glucagon secretion: It lowers inappropriate glucagon release, helping reduce the amount of glucose produced by the liver.\nSlows gastric emptying: Semaglutide can delay the movement of food from the stomach, contributing to prolonged fullness.\nReduces appetite: Its effects on appetite-regulating pathways in the brain can decrease hunger and food intake.\n2. Primary Indications & Uses\nSemaglutide may be prescribed for several clinically established purposes depending on the specific formulation, approved labeling, and patient's medical condition.\nType 2 Diabetes Management\nSemaglutide can be used alongside appropriate diet and physical activity to improve blood-glucose control in adults with type 2 diabetes.\nCardiovascular Risk Reduction\nIn eligible adults with type 2 diabetes and established cardiovascular disease, certain semaglutide products have demonstrated a reduction in the risk of major cardiovascular events, including cardiovascular death, non-fatal heart attack, and non-fatal stroke.\nKidney Disease\nCertain semaglutide formulations and indications have demonstrated kidney-related benefits in specific populations. The appropriate product and indication should be determined by a healthcare professional.\nChronic Weight Management\nSemaglutide is also used for long-term weight management in eligible adults with obesity or overweight accompanied by weight-related health conditions, depending on the approved formulation and local prescribing guidance.\n3. Key Benefits of Semaglutide 8 mg Therapy\nClinical Area\nPotential Therapeutic Role\nBlood-Glucose Control\nHelps lower elevated blood glucose and improve glycemic control in appropriate patients.\nWeight Management\nReduces appetite and food intake, supporting sustained weight reduction when prescribed for this purpose.\nCardiovascular Health\nCertain approved semaglutide indications can reduce major cardiovascular event risk in eligible patients.\nMetabolic Support\nInfluences glucose regulation, appetite, insulin secretion, and glucagon activity.\nWeekly Administration\nA once-weekly injection can provide a convenient treatment schedule when prescribed.\n\n4. Side Effects & Safety Warnings\nCommon Adverse Reactions\nDigestive symptoms are among the most frequently reported adverse effects, particularly when treatment is initiated or the dose is increased.\nPossible side effects include:\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nBloating\nBelching\nIndigestion or heartburn\nReduced appetite\nThese effects may improve as the body becomes accustomed to treatment.\nFrequently Asked Questions\n1. How much weight can you lose with semaglutide?\nWeight reduction varies significantly between individuals and depends on the prescribed formulation, dose, treatment duration, diet, physical activity, and adherence. Clinical trials of approved weight-management regimens have demonstrated substantial average percentage weight loss over extended treatment periods.\n2. How much is 8 units of semaglutide in mL?\nOn a U-100 insulin syringe, 100 units corresponds to 1 mL, so 8 units corresponds to 0.08 mL. However, this conversion only describes syringe volume. It does not determine the amount of semaglutide in mg because the medication concentration varies between products. Always verify the exact concentration before measuring any dose.\n3. Is semaglutide injection safe for weight loss?\nSemaglutide can be an effective treatment for weight management when an approved formulation is prescribed to an eligible patient and used under appropriate medical supervision. It has important contraindications and warnings, including risks involving the gastrointestinal system, gallbladder, pancreas, kidneys, and thyroid C-cell tumors.\n4. How many mg of semaglutide are used for weight loss?\nThe appropriate dose depends on the specific semaglutide product. Weight-management treatment commonly begins with a lower dose and is gradually increased to a maintenance dose to improve tolerability. The maintenance dose should be determined according to the product's approved prescribing information and the healthcare professional's instructions.\n5. How much weight can I lose in 2 months with semaglutide?\nThere is no guaranteed amount of weight loss during the first two months. Individual results vary because treatment generally begins at a lower dose and is increased gradually. Diet, physical activity, starting weight, medical conditions, and adherence also affect the result.\n6. What happens when you stop semaglutide?\nAfter discontinuation, semaglutide gradually leaves the body. Appetite and food intake may increase as its effects decrease, and some people regain weight. Maintaining healthy eating and physical activity habits may help support weight management after treatment, but discontinuation should be discussed with a healthcare professional.\n7. How long does an 8 mg/3 mL semaglutide pen last?\nIf a specific 8 mg/3 mL pen is designed to deliver 2 mg per weekly dose, it contains four 2 mg doses and therefore provides approximately four weeks of treatment. The actual duration depends on the specific device and prescribed dosing instructions.\n8. What is semaglutide injection 8 mg used for?\nSemaglutide is used for approved indications such as improving blood-glucose control in type 2 diabetes and, depending on the formulation, supporting chronic weight management and reducing cardiovascular risk in eligible patients.\n9. What foods should be avoided while taking semaglutide?\nLarge, high-fat, greasy, or fried meals may worsen gastrointestinal symptoms such as nausea, bloating, and reflux. Smaller meals and balanced food choices may be easier to tolerate. Alcohol intake should also be discussed with a healthcare professional.\n10. Can you eat bananas while taking semaglutide?\nYes, bananas can generally be included in a balanced diet while using semaglutide. Portion size should be considered as part of an individual's overall calorie and carbohydrate intake, particularly for people managing diabetes.\n11. What is the best time of day to inject semaglutide?\nSemaglutide injections can generally be administered at any time of day, with or without meals, depending on the specific product instructions. The injection should be taken on the same day each week as prescribed.\n12. Will I lose weight during the first week of semaglutide?\nSome people may notice an early change in appetite or body weight, while others may not see a significant difference initially. Early treatment doses are generally introduced gradually to help the body adjust rather than to produce immediate maximum weight loss.\n13. How quickly does semaglutide start lowering blood sugar?\nSemaglutide begins acting after administration, but the degree and timing of blood-glucose improvement vary. Significant treatment effects develop progressively, particularly as the prescribed dose is gradually adjusted.\n14. What should I do if I miss a semaglutide dose?\nThe correct missed-dose procedure depends on the specific semaglutide product. Follow the instructions supplied with your prescribed product. Do not take an extra dose to compensate for a missed injection.\n15. Where is the best place to inject semaglutide?\nSemaglutide is administered subcutaneously. Common injection sites include the abdomen, front of the thigh, or upper arm, according to the product instructions. Rotating injection locations can help reduce repeated irritation at one site.\nConclusion\nSemaglutide injection 8 mg contains semaglutide, a long-acting GLP-1 receptor agonist that influences blood-glucose regulation, glucagon secretion, gastric emptying, and appetite. Depending on the specific formulation and approved indication, semaglutide may be used for type 2 diabetes management, chronic weight management, and cardiovascular risk reduction in eligible patients.\nAn 8 mg/3 mL presentation designed for 2 mg weekly dosing can provide four weekly doses. However, semaglutide concentrations, pen designs, approved doses, and indications can differ between products. Treatment should therefore follow the exact product instructions and a healthcare professional's prescription.",
"price": 7800.0,
"discountamount": 2340.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2498,
"imageuri": "https://productimages.withfloats.com/actual/6a952bdd8359c1b7edbc7468.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a952bdd8359c1b7edbc7468.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-31T07:23:06.814Z",
"updatedon": "2026-08-31T07:23:06.814Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-8-mg/2498",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "SAMIGLUTIDE 8MG",
"category": "DIABETIC RANGE",
"tags": [
"Semaglutide injection 8 mg",
"semaglutide injection 8 mg",
"semaglutide 8 mg injection uses",
"semaglutide 8 mg injection benefits",
"semaglutide 8 mg injection dosage"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}